437 related articles for article (PubMed ID: 22567280)
1. Integrin signaling in cancer cell survival and chemoresistance.
Aoudjit F; Vuori K
Chemother Res Pract; 2012; 2012():283181. PubMed ID: 22567280
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
3. Alpha2beta1 integrin in cancer development and chemoresistance.
Naci D; Vuori K; Aoudjit F
Semin Cancer Biol; 2015 Dec; 35():145-53. PubMed ID: 26297892
[TBL] [Abstract][Full Text] [Related]
4. Integrin agonists as adjuvants in chemotherapy for melanoma.
Schwartz MA; McRoberts K; Coyner M; Andarawewa KL; Frierson HF; Sanders JM; Swenson S; Markland F; Conaway MR; Theodorescu D
Clin Cancer Res; 2008 Oct; 14(19):6193-7. PubMed ID: 18829498
[TBL] [Abstract][Full Text] [Related]
5. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
[TBL] [Abstract][Full Text] [Related]
6. Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance.
Zutter MM
Adv Exp Med Biol; 2007; 608():87-100. PubMed ID: 17993234
[TBL] [Abstract][Full Text] [Related]
7. Integrin control of tumor invasion.
Missan DS; DiPersio M
Crit Rev Eukaryot Gene Expr; 2012; 22(4):309-24. PubMed ID: 23272801
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.
Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D
Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910
[TBL] [Abstract][Full Text] [Related]
9. β3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD.
Nair MG; Desai K; Prabhu JS; Hari PS; Remacle J; Sridhar TS
Exp Cell Res; 2016 Aug; 346(1):137-45. PubMed ID: 27235542
[TBL] [Abstract][Full Text] [Related]
10. An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial-mesenchymal transition and chemoresistance acquisition.
Hoshiba T
Exp Cell Res; 2018 Sep; 370(2):571-578. PubMed ID: 30016638
[TBL] [Abstract][Full Text] [Related]
11. Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions.
Bozzo C; Bellomo G; Silengo L; Tarone G; Altruda F
Exp Cell Res; 1997 Dec; 237(2):326-37. PubMed ID: 9434628
[TBL] [Abstract][Full Text] [Related]
12. Targeting anoikis resistance in prostate cancer metastasis.
Sakamoto S; Kyprianou N
Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
[TBL] [Abstract][Full Text] [Related]
13. The integrin-extracellular matrix axis in pancreatic cancer.
Grzesiak JJ; Ho JC; Moossa AR; Bouvet M
Pancreas; 2007 Nov; 35(4):293-301. PubMed ID: 18090233
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance.
Gonzalez-Molina J; Moyano-Galceran L; Single A; Gultekin O; Alsalhi S; Lehti K
Semin Cancer Biol; 2022 Nov; 86(Pt 3):224-236. PubMed ID: 35331851
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
Rintoul RC; Sethi T
Clin Sci (Lond); 2002 Apr; 102(4):417-24. PubMed ID: 11914104
[TBL] [Abstract][Full Text] [Related]
16. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.
Uhm JH; Dooley NP; Kyritsis AP; Rao JS; Gladson CL
Clin Cancer Res; 1999 Jun; 5(6):1587-94. PubMed ID: 10389948
[TBL] [Abstract][Full Text] [Related]
17. Involvement of integrins in cell survival.
Bates RC; Lincz LF; Burns GF
Cancer Metastasis Rev; 1995 Sep; 14(3):191-203. PubMed ID: 8548868
[TBL] [Abstract][Full Text] [Related]
18. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.
Keely PJ
J Mammary Gland Biol Neoplasia; 2011 Sep; 16(3):205-19. PubMed ID: 21822945
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor.
Thomas F; Holly JM; Persad R; Bahl A; Perks CM
Prostate; 2010 Jun; 70(8):856-65. PubMed ID: 20127733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
